Answer
Fasenra (benralizumab) is used as an add-on treatment for adults with relapsing or refractory eosinophilic granulomatosis with polyangiitis (EGPA).
Sources for this answer
- Fasenra 30 mg solution for injection in pre filled penAstraZeneca UK Limited · emc · SmPC §4.1 Therapeutic Indications · Version 9Document updated
Sources checked